The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients.

Source:http://linkedlifedata.com/resource/pubmed/id/19327235

Download in:

View as

General Info

PMID
19327235